Article History
Received: 14 February 2022
Accepted: 8 May 2022
First Online: 23 May 2022
Disclosures
: MR received honoraria from Research to Practice, Intellisphere Physicians’ Education Resource, and MyMedEd; consulting/advisor from Artios Pharma (uncompensared), AstraZeneca (uncompensated), Change Healthcare, Daiichi-Sankyo (uncompensated), Epic Sciences (uncompensated), Merck (uncompensated), Pfizer (uncompensated), Tempus Lab (uncompensated), Zenith Pharma (uncompensated). Research funding from AstraZeneca (Institution), Merck (Institution), and Pfizer (institution). GC and VS have not disclosure to declare.